J&J Ruling Removes FDA Warnings From Plaintiff Playbook
By Sindhu Sundar ( March 21, 2014, 8:13 PM EDT) -- The Arkansas Supreme Court's surprise reversal of a landmark $1.2 billion judgment against Johnson & Johnson on Thursday held that U.S. Food and Drug Administration warning letters are often too prejudicial to use as evidence against pharmaceutical companies, eliminating a powerful tool that plaintiffs have relied on to sway juries....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.